Research Study #20
Feb 02, 2022
Reduction of halitosis by a tablet containing Weissella cibaria CMU: A randomized, double-blind, placebo-controlled study
Conclusions
According to the results of the clinical trial conducted in 100 participants, the reduction of halitosis after a 4-week intake of oraCMU was statistically significant.
To read more in-dept, click here